Jianbo Biotechnology

健泊生物

Jianbo Biotechnology

Biotech/Healthcare

Jianbo is a developer of pharmaceuticals for cancer and oral diseases. Based on its proprietary IROSS new-drug development platform, it has developed SOOS-1, a drug designed to inhibit the development of tumor resistance, as well as reagents for assessing the likelihood of cancer occurrence.

Latest round: Strategic (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-11-01